Novelion unit asks U.S. judge to approve plea deal, cites money woes

BOSTON (Reuters) – Aegerion Pharmaceuticals Inc has asked a U.S. judge to quickly approve a new plea agreement aimed at resolving probes into its promotion of a cholesterol drug, saying its parent company has been blocked from capital markets due to the case’s uncertainty.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *